Share on Social Media

Queensland Research Partners

Queensland Centre for Gynaecological Cancer

The Queensland Centre for Gynaecological Cancer (QCGC) represents a state-wide service for the management of women with gynaecological cancer in Queensland. It is the research branch of QCGC and an accredited research centre within The University of Queensland.

It is an academic (non-profit) institution housed at the Royal Brisbane and Women’s Hospital (Herston, Brisbane). QCGC works in partnership with Queensland Health for the State’s gynaecological cancer services.

Eight certified gynaecological oncologists currently operate on more than 3000 women with suspected or proven gynaecological cancer in Queensland.

QCGC Research aims to develop the best standard of care for women suffering from gynaecological cancer. This includes finding the causes, reaching better prevention and detection methods, and finding better treatment options to cure women affected by gynaecological cancer.

QCGC Research focuses on surgical clinical trials in the field of gynaecological cancer, but also performs ground-breaking work outside the conventional clinical trials framework.

Professor Andreas Obermair leads a small group of research staff, students (PhD and MD students) and other staff located mostly at RBWH. [Link to Prof Obermair profile in directors area of website]
Examples of past research can be found here.

The following hospitals are affiliated with the Queensland Centre for Gynaecological Cancer and currently collaborate on clinical trials and other research studies that are funded by the Cherish Women’s Cancer Foundation:

  • Royal Brisbane and Women’s Hospital (Assoc Prof Jim Nicklin, Professor Andreas Obermair, Assoc Prof
  • Russell Land, Dr Andrea Garrett)
  • Mater Health Services Brisbane (Assoc Prof Lew Perrin, Dr Alex Crandon, Dr Nevan Chetty)
  • Greenslopes Private Hospital (Prof Andreas Obermair, Assoc Prof Russell Land)
  • The Wesley Hospital (Assoc Prof Jim Nicklin, Dr Andrea Garrett)
  • Gold Coast Hospital (Dr Marcelo Nascimento)

 

Queensland University of Technology (QUT)

QUT’s Institute of Health and Biomedical Innovation has been an invaluable collaborator in gynaecological cancer research for many years.
[Kym to get two paragraphs together to fill this out more]

Associate Professor Monika Janda

Dr Monika Janda is a Senior Research Fellow at the School of Public Health and specialises in behavioural science and health psychology. Dr Janda’s research has two main aims;
1. to improve the early detection of cancer and;
to improve cancer survivors’ quality of life.

Dr Janda is an investigator on a number of gynaecological cancer clinical trials, such as the LACE trial, which revealed ground-breaking information on the recovery from laparoscopic and open surgery for uterine cancer. Monika is also a lead investigator to examine fertility-sparing treatment of endometrial cancer.

Associate Professor Sandi Hayes
Dr Sandi Hayes is an exercise physiologist and Senior Research Fellow at the School of Public Health. Dr Hayes’ current research focus is on the understanding of physical and psychological concerns following cancer, and in particular lymphoedema. She is also an expert in the study of the role of physical exercise in cancer recovery.
Dr Hayes is currently involved in projects to develop exercise prescription guidelines for lymphoedema for patients diagnosed with various types of cancer. In particular Sandi is involved in a prospective study to determine the risk factors for developing lymphoedema in women diagnosed and treated for gynaecological cancer.

 

Queensland Institute of Medical Research (QIMR)

QIMR is one of the largest medical research institutes in Australia and conducts a number of world-leading studies on gynaecological cancer.

The Australian National Endometrial Cancer Study (ANECS) represents collaboration between epidemiologists, geneticists, molecular biologists and clinicians. ANECS identifies possible causes of endometrial cancer and in particular leads the field in hereditary endometrial cancer internationally (Lead: Asoc Prof Amanda Spurdle).
The Australian Ovarian Cancer Study (AOCS) led by Assoc Prof Penny Webb is the largest collaborative research program between clinicians, scientists, patients and advocacy groups on the prevention, diagnosis, and treatment of ovarian cancer. Penny is also the Principal Investigator for the OPAL Study examining factors that influence survival chances following ovarian cancer treatment.

The Cherish Women’s Cancer Foundation will endeavour to raise funds to deepen our understanding of molecular causes and prognostic factors of uterine and ovarian cancer.

 

Australian Centre for Health Services Innovation

Professor Nick Graves is a Principal Research Fellow at the Faculty of Health at QUT. He is the founder of the Australian Centre for Health Services Innovation (AusHSI) that builds Health Services Research capacity and delivers solutions to important health services. Nick and our centre collaborated in the past on the cost effectiveness of new innovative surgical techniques. In collaboration with QCGC Research Nick found that minimally invasive surgery is not only better for women who need a hysterectomy, but also it is also cheaper for society.

 

Cancer Council Queensland

Danny Youlden and Peter Baade are statisticians at the Cancer Council Queensland’s Viertel Centre for Research in Cancer Control for many years. Both researchers analyse population-based cancer data, as well as contributing biostatistical support to other researchers within and outside their centre. Danny and Peter are the lead authors on several reports examining the descriptive epidemiology of cancer in Queensland as well as childhood cancer throughout Australia. Peter and Danny helped QCGC Research to complete several studies that linked very large data sets to examine the relationship between breast and gynaecological cancer.

 

School of Biomedical Sciences (UQ)

Professor Chen Chen is the Professor and Chair of Endocrinology from 2008 in the University of Queensland after serving as the Head of the Endocrine Cell Biology at the Prince Henry’s Institute of Medical Research, Melbourne, 1999-2007. He is a Principal Research Fellow of the Australian NHMRC. The Chen laboratory focuses on the link of cell biological properties and functions. In his research he concentrates on hormones, which are important in controlling growth, development, metabolic balance, body mass composition, and the ageing process.

 

Australian Research Partners:

  • Monash Medical Centre (Dr Tom Manolitsas, Assoc Prof Tom Jobling)
  • Royal Women’s Hospital (Professor Michael Quinn, Dr Orla McNally, Dr Deborah Neesham, Dr Chris Wrede)
  • St John of God Hospital (Dr Stuart Salfinger, Professor Ian Hammond)
  • King Edward Memorial Hospital (Prof Yee Leung, Dr Stuart Salfinger)
  • Westmead Hospital (Dr Russell Hogg, Dr Alison Brand)
  • John Hunter Hospital (Dr Geoff Otton)
  • Royal Prince Alfred Hospital (Assoc Prof Selvan Pather, Professor Jonathan Carter)
  • Royal North Shore Hospital (Dr Sue Valmadre)
  • Royal Hospital for Women (Dr Rhonda Farrell, Dr Greg Robertson)
  • Royal Adelaide Hospital (Assoc Prof Martin Oehler)
  • Hollywood Private Hospital (Dr Jason Tan)
  • Calvary North Adelaide Hospital (Dr John Miller)
  • Royal Hobart Hospital (Dr Michael Bunting)
  • NHMRC Clinical Trial Centre, Sydney (Professor Val Gebski)

 

International Research Partners:

  • Christchurch Women’s Hospital, New Zealand (Professor Peter Sykes, Dr Mike Lane, Dr Bryony Simcock)
  • Queen Mary Hospital, Hong Kong (Professor Hextan Ngan, Dr Karen Chan, Dr Ng Tong Yow, Dr Tam Kar Fai)
  • Royal Infirmary of Edinburgh, Scotland (Dr Graham Walker)
  • MD Anderson Cancer Centre (Professor Pedro Ramirez, Dr Michael Frumovitz)
  • PORTEC Clinical Trials Unit, The Netherlands (Professor CL Creutzberg)